On May 22, 2026, the four‑day 31st Hospitalar – Brazil International Medical and Hospital Equipment Exhibition successfully concluded in São Paulo. As the largest and most influential medical event in Latin America, this year’s exhibition attracted more than 85,000 professional visitors and 1,272 global medical companies from 55 countries, fostering in‑depth exchanges on medical innovation, hospital management, digital technologies, and other forward‑looking topics.
Surgsci Medical Ltd. participated with a dedicated team, engaging with partners from Latin America and around the world to explore trends in medical technology and demonstrate the strength of Chinese innovation on the global stage.





Extensive Engagement and Strong Connections in Latin America
Throughout the exhibition, the Surgsci booth at H‑250B maintained a dynamic and professional atmosphere. Representatives from hospitals, distributors, channel partners, and industry experts visited our booth to discuss a wide range of topics, including minimally invasive surgery, urology solutions, hospital application scenarios, and technological innovation.
As a central hub of the Latin American medical market, Hospitalar provided Surgsci with a high‑quality platform to connect with local healthcare systems, distribution networks, and potential partners.
Open Collaboration and New Opportunities
During the four‑day event, we engaged in extensive discussions with professional visitors from Brazil, Argentina, Chile, Peru, Mexico, and several other countries. Through on‑site demonstrations and face‑to‑face communication, many attendees expressed strong interest in our technologies and products, recognizing their performance and clinical value.
These insights from diverse markets deepened our understanding of clinical needs, channel structures, and regulatory environments across Latin America. They also provided valuable guidance for Surgsci’s regional development and strengthened the foundation for future global cooperation.

Continuous Innovation and Global Progress
Although Hospitalar 2026 has come to a successful close, Surgsci’s global expansion continues. Guided by our mission to improve health and quality of life, we remain committed to clinical‑driven innovation, product advancement, and international collaboration. Surgsci will continue to provide efficient, precise, and safe solutions for healthcare systems worldwide.
We extend our sincere appreciation to every visitor who stopped by the Surgsci booth. We look forward to working together to explore broader opportunities in the global market.











